Company Profile

Evrys Bio LLC (AKA: Forge Life Sciences LLC)
Profile last edited on: 12/14/2023      CAGE: 5UBY1      UEI: TM98GAF3Z6Q6

Business Identifier: Novel broad-spectrum anti-viral therapies: first-in-class antivirals safe - addressing problem of acquired drug-resistance, and providing unique broad-spectrum treatment options
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3805 Old Easton Road
Doylestown, PA 18902
   (267) 893-6755
Location: Single
Congr. District: 01
County: Bucks

Public Profile

Evrys Bio - formerly dba Forge Life Sciences LLC - is a pre-clincial biotechnology company developing anti-viral treatments. Anchored in technology licensed from Princeton University, Evrys Bio is developing anti-viral therapies based on sirtuin modulators. Traditional antivirals are direct-acting antivirals targeting a protein of a specific virus limiting their effectiveness against more than one virus type. Where immuno-oncology drugs engage the patient’s immune system to fight cancer, Evrys Bio antivirals engage the cell’s intrinsic immunity to defend against infection. The vision is to develop first-in-class antivirals that are safe, address the problem of acquired drug-resistance, and provide unique broad-spectrum treatment options. If successful, the approach could potentially transform the practice of medicine - addressing the infectious disease condition as opposed to targeting a specific virus-type. The physician would be prescribing a safe, broad-spectrum antiviral, without the risk of acquired drug-resistance, based on symptom presentation, and prior to diagnostic confirmation of infecting virus-type.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Lillian W Chiang -- Founder, President and Chief Executive Officer

  Justine Bucholz -- Chief of Operations and Project Management

  F Aaron Dubberley -- Head of Intellectual Properties

  Dana M Fowlkes -- Chief Business Officer

  Emre Koyuncu -- Head of Biology

  Eain A Murphy -- Head of Biology

  Stacy W Remiszewski -- Head of Chemistry

  Thomas E Shenk -- Founder and Board Director

  Matthew Todd -- Head of Enzymology and Biophysics

  James Tonra -- Chief Scientific Officer